Crosstalk Between MicroRNAs and Circular RNAs in Human Diseases: A Bibliographic Study
Yu-Meng Chen
Yi-Li Zheng
Xuan Su
Xue-Qiang Wang- 1Department of Sport Rehabilitation, Shanghai University of Sport, Shanghai, China
- 2Shanghai Shangti Orthopaedic Hospital, Shanghai, China
Background: Crosstalk of circular RNAs (circRNAs) and microRNAs (miRNAs) refers to the communication and co-regulation between them. circRNAs can act as miRNAs sponges, and miRNAs can mediate circRNAs. They interact to regulate gene expression and participate in the occurrence and development of various human diseases.
Methods: Publications on the crosstalk between miRNAs and circRNAs in human diseases were collected from Web of Science. The collected material was limited to English articles and reviews. CiteSpace and Microsoft Excel were used for bibliographic analysis.
Results: A total of 1,013 papers satisfied the inclusion criteria. The publication outputs and types of researched diseases were analyzed, and bibliographic analysis was used to characterize the most active journals, countries, institutions, keywords, and references. The annual number of publications remarkably increased from 2011 to 2020. Neoplasm was the main research hotspot (n = 750 publications), and Biochemical and Biophysical Research Communications published the largest number of papers (n = 64) on this topic. Nanjing Medical University ranked first among institutions actively engaged in this field by publishing 72 papers, and China contributed 96.84% of the 1,013 papers (n = 981 publications) analyzed. Burst keywords in recent years included glioblastoma, miR-7, skeletal muscle, and non-coding RNA.
Conclusion: Crosstalk between miRNAs and circRNAs in human diseases is a popular research topic. This study provides important clues on research trends and frontiers.
Introduction
MicroRNAs (miRNAs) are endogenous non-coding RNAs (ncRNAs) measuring ∼22 nucleotides in length; they were first discovered in 1993 (Lee et al., 1993; Bartel, 2004). Lee et al. (1993) reported that lin-4 negatively regulates the expression of lin-14 protein by binding to the 3′-untranslated region (3′UTR) of lin-14 messenger RNA (mRNA) in Caenorhabditis elegans. miRNAs are crucial post-transcriptional regulators of gene expression and known to pair with the 3′UTR of target mRNAs to either induce mRNA degradation or inhibit translation (Bartel, 2009). Moreover, these RNAs have been reported to be involved in the processes of various diseases, such as cancer (Iacona and Lutz, 2019; Iqbal et al., 2019), chronic pain (Lopez-Gonzalez et al., 2017; Tramullas et al., 2018), and cardiac diseases (Colpaert and Calore, 2019; Fitzsimons et al., 2020).
Circular RNAs (circRNAs) are endogenous ncRNAs with covalent closed-loop structures that were first discovered in viral RNA by Sanger et al. (1976). circRNAs possess high stability on account of their unique structure, which protects them from degradation by exonucleases (Jeck et al., 2013). This type of RNA has been confirmed to modulate gene expression by acting as miRNA sponges (Hansen et al., 2013a; Memczak et al., 2013) or RNA binding protein regulators (Li et al., 2015). Similar to miRNAs, circRNAs are involved in a number of human diseases, such as cancer (Wang et al., 2017; Patop and Kadener, 2018), neurodegenerative disorders (Floris et al., 2017; Huang et al., 2020), and cardiovascular diseases (Aufiero et al., 2019; Zhang et al., 2020).
Crosstalk of circRNAs and miRNAs refers to the communication and co-regulation between them. As two important gene-expression regulators, circRNAs interact with miRNAs and participate in regulating mRNA expression in various human diseases (Hansen et al., 2013a; Kristensen et al., 2019). Crosstalk between miRNAs and circRNAs has been extensively studied, but the relevant mechanisms remain incompletely understood. To date, two mechanisms have been identified: (1) circRNAs act as miRNA inhibitors/sponges. ciRS-7 (circular RNA sponge for miR-7), one of the most typical circRNAs, has been observed to show overlapping co-expression with miR-7 in mouse brain. ciRS-7 can sponge miR-7 to inhibit miR-7 activity extensively, thereby increasing the levels of miR-7 target genes (Hansen et al., 2013a). (2) miRNAs mediate circRNAs. ciRS-7, also known as CDR1as, has been confirmed to be cleaved by Argonaute 2 via miR-671 mediation in cultured cells (Hansen et al., 2011) and mouse brain (Kleaveland et al., 2018). Furthermore, ciRS-7 and its crosstalk with miRNAs have been found to exert a significant effect on sensorimotor gating and synaptic transmission (Piwecka et al., 2017).
Crosstalk between circRNAs and miRNAs may provide new avenues through which the mechanisms, diagnosis, and treatment of human diseases could be explored. Thus, in the present work, we provide a bibliographic analysis of the related literature to identify current global research trends and emerging topics in this field.
Materials and Methods
Data Acquisition and Inclusion Criteria
This bibliographic analysis included published articles and reviews that related to research on the crosstalk between circRNAs and miRNAs, and these publications focused on the occurrence and development of human diseases or might be beneficial for studying human diseases. Data were extracted from Science Citation Index Expanded (SCI-Expanded) of Web of Science (WoS) in March 2021. Searches were conducted using the following keywords: TI = (circRNA∗ or “circ RNA∗” OR “circular RNA∗” OR circularRNA∗) AND TI = (microRNA∗ OR mir∗ OR miRNA∗ OR “micro RNA∗” OR “small non-coding RNAs” OR “small non-coding RNA” OR “small RNA∗”).
Supplementary Figure 1 shows the process of literature selection. Language was restricted to English, and no species limitation was implemented. We selected articles and reviews, and excluded all other publication types, such as meeting abstracts and corrections. Studies focusing on human diseases were included, while research on other subjects, such as plants, were excluded. The search and screening process was performed by two authors; in the event of disagreement, the final decision was made by the corresponding author.
Analytical Tools and Key Indicators
Microsoft Excel 2019 and CiteSpace V (version: 5.6.R5; Drexel University) were used for bibliographic analysis, and SPSS 22.0 (SPSS Inc., Chicago, IL, United States) was used for statistical analysis. CiteSpace is often used for bibliographic analysis with data derived from WoS (Liu et al., 2019; Xu and Sun, 2020; Yan et al., 2020). International Classification of Diseases 11th Revision (ICD-11) was used to classify the diseases evaluated in the 1,013 papers we obtained (World Health Organization [WHO], 2021).
The number of publications and citations, journal impact factor (JIF, 2019), h-index, category and JIF quartile were collected from WoS. The productivity of an individual or group was reflected by the number of articles published. The number of citations, IF and h-index were collected to assess the impact of individuals or groups on publications in this filed. IF values were acquired from Journal Citation Reports (2021), which is a highly suitable index for evaluating the influence of journals (Garfield, 2006). The h-index characterizes the scientific output of a researcher. If the h-index of a researcher is h, the researcher published at least h papers and each of these papers was cited at least h times (Hirsch, 2005). Each journal was assigned to at least one category in descending order according to JIF, and the top 25% of JIF distribution were Q1, 25–50% were Q2 and 50–75% were Q3. Centrality is an indicator calculated by CiteSpace to evaluate the importance of nodes in a network; nodes with high centrality indicate pivotal points (Chen, 2006).
Results
Publication Output
A total of 1,013 papers were included in our study. Figure 1A shows the number of articles published by year. The first paper related to the crosstalk between miRNAs and circRNAs in human diseases was published in 2011. The number of publications increased from 1 in 2011 to 535 in 2020. As of February 28, 2021, 40 papers on this topic have been published in 2021. Figure 1B shows the total number of citations of the 1,013 papers per year. Linear regression analysis showed that the number of publications (t = 3.376, P = 0.01 < 0.05, data of 2021 were not included because they are incomplete) and citations (t = 3.413, P = 0.009 < 0.05, data of 2021 were not included) increased remarkably each year from 2011 to 2020.
Figure 1. The number of publications and citations. (A) The number of annual publications on the crosstalk between microRNAs and circular RNAs from 2011 to 2021; (B) The number of annual citations on the crosstalk between microRNAs and circular RNAs from 2011 to 2021.
Distribution of Diseases
The research directions of the 1,013 papers were classified and summarized according to ICD-11. Table 1 shows the top 10 diseases studied. Neoplasm was the most popular research topic related to the crosstalk between miRNAs and circRNAs (n = 750 publications; 74.04% of the total number of publications) and had an h-index of 56; this topic was followed by diseases of the circulatory system (n = 62 publications; h-index = 17) and musculoskeletal system or connective tissue (n = 57 publications; h-index = 15).
Table 1. The top 10 diseases ranked by number of publications.
Distribution by Journals
A total of 244 journals contributed the 1,013 papers included in this study. Among the top 10 journals ranked by number of publications (Table 2), Biochemical and Biophysical Research Communications contributed the greatest number of publications (n = 64) and had the highest h-index (33), followed by European Review for Medical and Pharmacological Sciences (n = 43 publications) and Journal of Cellular Biochemistry (n = 38 publications). The IF of the top 10 journals ranged from 2.886 to 15.302 (mean = 5.4113). Among the journals contributing publications on the crosstalk between miRNAs and circRNAs in human diseases, Molecular Cancer (n = 26 publications) had the highest IF (IF 2019 = 15.302), followed by Molecular Therapy-Nucleic Acids (n = 28 publications; IF 2019 = 7.032) and Cell Death and Disease (n = 25 publications; IF 2019 = 6.304). Among the top 10 journals, 33.33% JIF quartile were Q1, 46.67% were Q2 and 20% were Q3.
Table 2. The top 10 journals ranked by number of publications.
A dual map of journals presenting contributions and connections between disciplines is shown in Figure 2. The left-hand side of the map presents citing journals, whereas the right-hand side presents cited journals. The 1,013 papers obtained from our database search were mostly published in journals dedicated to molecular, biology and immunology field, and cited journal publications on molecular, biology, and genetics field.
Figure 2. The dual-map overlay of journals that published articles on the crosstalk between microRNAs and circular RNAs.
Distribution by Countries and Institutions
In total, 30 countries and 748 institutions contributed to the related research, and the details of each item can be found in Supplementary Tables 1, 2. Figures 3A,B, respectively, show the contributions and collaborations by country and by institution. The distribution of countries is presented in Figure 4. Table 3 shows the top 10 countries ranked by distribution of publications. China contributed 96.84% of the 1,013 papers (n = 981 publications), with a high centrality of 0.57. The United States revealed the highest centrality (0.59) and contributed the second highest number of publications (n = 42).
Figure 3. The analysis of countries/regions and institutions. (A) Network map of countries/regions engaged in research on the crosstalk between microRNAs and circular RNAs; (B) Network map of institutions engaged in research on the crosstalk between microRNAs and circular RNAs.
Figure 4. World map of countries/regions that published articles on the crosstalk between microRNAs and circular RNAs.
Table 3. The top 10 countries ranked by number of publications.
The top 10 institutions ranked by number of publications were all universities in China (Table 4). Among these institutions, Nanjing Medical University ranked first (n = 72 publications), followed by Zhengzhou University (n = 43 publications) and Sun Yat-sen University (n = 41 publications).
Table 4. The top 10 institutions ranked by number of publications.
Analysis of Keywords
The top 20 keywords with the strongest citation bursts at different time periods are shown in Figure 5. Messenger RNA was the first keyword with the strongest citation burst, which began in 2011 and ended in 2016. Glioblastoma, mir-7, skeletal muscle, and ncRNA were keywords with strong citation bursts that lasted until 2020. Among these four keywords, glioblastoma revealed the highest strength (3.5635) and was the first to burst (in 2013).
Figure 5. The top 20 keywords with the strongest citation bursts of publications on the crosstalk between microRNAs and circular RNAs.
Analysis of References
References are an indispensable part of publications. Figure 6 illustrates a timeline view of references in the 1,013 publications related to the crosstalk between microRNAs and circRNAs in human diseases. The timeline view was constructed using CiteSpace, and the cluster labels were extracted from the keywords. Figure 6 shows the top 8 clusters, the first of which is marked #0. Gastric cancer revealed the largest cluster, followed by miRNA sponge (#1), ovarian cancer (#2), and glioma (#3).
Figure 6. The analysis of references. Co-citation map (timeline view) of references from publications on the crosstalk between microRNAs and circular RNAs.
Discussion
In this study, we performed a bibliographic analysis of studies on the crosstalk between miRNAs and circRNAs and found that research on this topic is well underway. circRNAs can communicate and co-regulate with miRNAs to regulate gene expression. Hansen and his colleagues published the first paper on the crosstalk between ciRS-7 and miR-671 in 2011 (Hansen et al., 2011). However, the number of publications on this subject exceed 10 per year until 2016. Thereafter, publications exceeded 100 papers per year in 2018 and reached 535 papers per year in 2020.
The mechanisms of crosstalk between miRNAs and circRNAs are incompletely understood. miRNAs and circRNAs have been proven to interact in the pathological process of many human diseases, including cancer, osteoarthritis (OA) and neuropathic pain (NP). circRNAs sponging miRNAs was a frequently mentioned mechanism of the crosstalk between circRNAs and miRNAs in human diseases. Zheng et al. (2016) revealed that circHIPK3, a circRNAs differently expresses between cancer and normal tissues, has 18 potential binding sites and can sponge 9 miRNAs to modulate human cell proliferation. Liu et al. (2016) reported that circRNA-CER competitively binds miR-136 to regulated MMP13 expression and participated in the degradation of chondrocyte extracellular matrix. Several circRNAs have been confirmed to regulate mRNA expression by sponge miRNAs, and then involved in neuroinflammation, neuronal autophagy, cell proliferation, and central sensitization in NP (Song et al., 2020). About the mechanisms of cancer, Hanse found miR-671 can directionally cleave ciRS-7 to release miR-7 that sponged by ciRS-7 (Hansen et al., 2013b). However, few studies researched the mechanism of miRNAs mediating circRNAs.
Neoplasms are the most common condition associated with research on the crosstalk between miRNAs and circRNAs; indeed, articles discussing neoplasms made up 74.04% of the total number of publications obtained, with a high h-index (56). Han and his colleagues revealed that circMTO1 inhibits the process of hepatocellular carcinoma by sponging miR-9 (Han et al., 2017). Zhang and his colleagues found that circFGFR1 upregulates the expression of CXCR4, the miR-381-3p target gene, to promote the progression of non-small cell lung cancer by miR-381-3p (Zhang et al., 2019b). The research findings of Zhang et al. (2017) were published in Molecular Cancer, which had the highest IF among the top 10 journals ranked by number of publications. Interactions between miRNAs and circRNAs have also been explored in other types of neoplasms, such as gastric cancer, breast cancer (Yang et al., 2019) and glioma (Xu et al., 2018). Most of the related research focuses on malignant tumors and the mechanism of circRNA as a miRNA sponge.
Biochemical and Biophysical Research Communications contributed the most to research on the crosstalk between miRNAs and circRNAs by publishing 64 articles with the highest h-index (33). However, in terms of IF, this journal placed ninth among the top 10 journals ranked by number of publications. Molecular Cancer, the IF of which was 15.302, was the only journal with an IF greater than 10 among the top 10 journals. Although the IF of the top 10 journals was not high, JIF Quartile shown that these journals ranked well in corresponding categories (33.33% of Q1 and 46.67% of Q2). These results suggest that the quality of most publications was reliable, but more high quality and ground-breaking researches are needed in this field. Furthermore, the crosstalk between circRNAs and miRNAs is a relatively new field, and it may be a possible reason for these results.
China is the major country contributing research on the crosstalk between miRNAs and circRNAs in human diseases. The country published 981 papers (96.84% of the total number of articles included in this work) and showed fairly high centrality (0.57). The United States ranked second in terms of countries with the greatest number of publications; the country published 42 papers and demonstrated the highest centrality (0.59) among the countries compared. Interestingly, China noticeably contributed more publications than the United States, but the centrality of the former was lower than that of the latter. This finding may be explained by the vast number of articles published by China alone, which could result in low centrality. The top 10 institutions ranked by number of publications were all Chinese universities, among which Nanjing Medical University ranked first, with 72 publications. Therefore, China is the leading country in research on the crosstalk between miRNAs and circRNAs in human diseases, and universities are the main institutional form in this field.
According to CiteSpace V, “glioblastoma,” “miR-7,” “skeletal muscle,” and “non-coding RNA” are the most popular keywords in the related research; these terms indicate potential research hotspots and frontiers. The four potential frontiers of research on the crosstalk between miRNAs and circRNAs in human diseases are as follows:
(1) Glioblastoma: Glioblastoma multiforme (GBM), the most common type of brain cancer, is also known as grade IV glioma; the disease has a short overall survival time and high malignancy (Westphal and Lamszus, 2011; Louis et al., 2016). Although therapeutic strategies for this disease have been improved, GBM remains difficult to treat (Omuro and DeAngelis, 2013). circRNAs and miRNAs play important roles in many malignancies, and their crosstalk in GBM remains unclear. Thus, research on this field has great potential therapeutic significance.
(2) MiR-7: miR-7 can modulate the expression of several oncogenes, and changes in miR-7 activity can affect the progression of cancer (Hansen et al., 2013b). The mechanism underlying the crosstalk between circRNAs and miR-7 in human diseases is a research hotspot.
(3) Skeletal muscle: Skeletal muscle, which contains 50–75% of all proteins in the human body, accounts for approximately 40% of the human body weight. Skeletal muscle is closely related to human locomotion and metabolism, and skeletal muscle diseases can severely affect a patient’s quality of life (Frontera and Ochala, 2015). circRNAs and miRNAs can regulate the development of skeletal muscle, and the crosstalk between these RNAs is a research frontier (Ge and Chen, 2011; Zhang et al., 2019a).
(4) Non-coding RNA: Research conducted over the last decade has reported that ncRNAs are involved in several physiological and pathological processes. circRNAs and miRNAs are two types of ncRNAs that do not code proteins but can regulate gene expression. The effect of crosstalk between circRNAs and miRNAs on the complex and unknown regulatory networks of ncRNA must be further investigated (Panni et al., 2020).
According to our analysis of keywords and references, research on the crosstalk between circRNAs and miRNAs mainly focuses on cancer, including glioma, gastric cancer, and ovarian cancer, and the related sponge mechanism. Journals in molecular, biology and genetics field were the main source of references for the published research. Most publications were published in journals dedicated to molecular, biology and immunology field.
To the best of our knowledge, this study is the first to use CiteSpace to perform a bibliographic analysis of publications on the crosstalk between miRNAs and circRNAs. However, this study presents some limitations. First, SCI-E of WoS, although an authoritative and comprehensive database in the medical field, was the only resource we selected for data acquisition; thus, some important findings published in other databases may have been missed. Second, the contributions and collaborations of authors were not analyzed because most of the authors were from China and different Chinese names could be translated to the same English name. Third, this study lacked an assessment of the overall quality of publications.
Conclusion
A total of 1,013 papers on the crosstalk between miRNAs and circRNAs in human diseases were published. The first paper was published in 2011 and initiated research in this field. The quality of most publications was relatively well in this field, but high-impact researches were needed. Biochemical and Biophysical Research Communications contributed the most to this field in terms of number of publications, and China produced the largest amount of research on this topic. In terms of institution, Nanjing Medical University published the largest number of related articles. At present, cancer is the most popular research area related to the crosstalk between miRNAs and circRNAs in human diseases. The latest burst keywords are “glioblastoma,” “miR-7,” “skeletal muscle,” and “non-coding RNA.” As far as we know, no bibliographic analysis has been conducted for publications on the crosstalk between circRNAs and miRNAs before. This study may provide researchers important clues on research trends and frontiers in this field.
Data Availability Statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
Author Contributions
Y-MC and X-QW: conceptualization and visualization. Y-MC: data curation, formal analysis, methodology, and writing – original draft. X-QW: funding acquisition and supervision. Y-MC, Y-LZ, XS, and X-QW: validation. Y-MC, Y-LZ, and XS: writing, review, and editing. All authors contributed to the article and approved the submitted version.
Funding
This research was funded by the National Natural Science Foundation of China, grant number 81871844; Shuguang Program supported by Shanghai Education Development Foundation and Shanghai Municipal Education Commission, grant number 18SG48; the Shanghai Municipal Commission of Health and Family Planning, grant number 201840346; the Shanghai Key Lab of Human Performance (Shanghai University of Sport), grant number 11DZ2261100; and Shanghai Frontiers Science Research Base of Exercise and Metabolic Health.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2021.754880/full#supplementary-material
Supplementary Figure 1 | Flowchart of literature selection on the crosstalk between microRNAs and circular RNAs in human diseases.
References
Aufiero, S., Reckman, Y. J., Pinto, Y. M., and Creemers, E. E. (2019). Circular RNAs open a new chapter in cardiovascular biology. Nat. Rev. Cardiol. 16, 503–514. doi: 10.1038/s41569-019-0185-2
Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297. doi: 10.1016/s0092-8674(04)00045-5
Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233. doi: 10.1016/j.cell.2009.01.002
Chen, C. (2006). CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J. Am. Soc. Inform. Sci. Technol. 57, 359–377. doi: 10.1002/asi.20317
Colpaert, R. M. W., and Calore, M. (2019). MicroRNAs in cardiac diseases. Cells 8:737. doi: 10.3390/cells8070737
Fitzsimons, S., Oggero, S., Bruen, R., McCarthy, C., Strowitzki, M. J., Mahon, N. G., et al. (2020). microRNA-155 is decreased during atherosclerosis regression and is increased in urinary extracellular vesicles during atherosclerosis progression. Front. Immunol. 11:576516. doi: 10.3389/fimmu.2020.576516
Floris, G., Zhang, L., Follesa, P., and Sun, T. (2017). Regulatory role of circular RNAs and neurological disorders. Mol. Neurobiol. 54, 5156–5165. doi: 10.1007/s12035-016-0055-4
Frontera, W. R., and Ochala, J. (2015). Skeletal muscle: a brief review of structure and function. Calcif Tissue Int. 96, 183–195. doi: 10.1007/s00223-014-9915-y
Garfield, E. (2006). The history and meaning of the journal impact factor. JAMA 295, 90–93. doi: 10.1001/jama.295.1.90
Ge, Y., and Chen, J. (2011). MicroRNAs in skeletal myogenesis. Cell Cycle 10, 441–448. doi: 10.4161/cc.10.3.14710
Han, D., Li, J., Wang, H., Su, X., Hou, J., Gu, Y., et al. (2017). Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology 66, 1151–1164. doi: 10.1002/hep.29270
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., et al. (2013a). Natural RNA circles function as efficient microRNA sponges. Nature 495, 384–388. doi: 10.1038/nature11993
Hansen, T. B., Kjems, J., and Damgaard, C. K. (2013b). Circular RNA and miR-7 in cancer. Cancer Res. 73, 5609–5612. doi: 10.1158/0008-5472.CAN-13-1568
Hansen, T. B., Wiklund, E. D., Bramsen, J. B., Villadsen, S. B., Statham, A. L., Clark, S. J., et al. (2011). miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J. 30, 4414–4422. doi: 10.1038/emboj.2011.359
Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proc. Natl. Acad. Sci. U. S. A. 102, 16569–16572. doi: 10.1073/pnas.0507655102
Huang, J. L., Su, M., and Wu, D. P. (2020). Functional roles of circular RNAs in Alzheimer’s disease. Ageing Res. Rev. 60:101058. doi: 10.1016/j.arr.2020.101058
Iacona, J. R., and Lutz, C. S. (2019). miR-146a-5p: expression, regulation, and functions in cancer. Wiley Interdiscip. Rev. RNA 10:e1533. doi: 10.1002/wrna.1533
Iqbal, M. A., Arora, S., Prakasam, G., Calin, G. A., and Syed, M. A. (2019). MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol. Aspects Med. 70, 3–20. doi: 10.1016/j.mam.2018.07.003
Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., et al. (2013). Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19, 141–157. doi: 10.1261/rna.035667.112
Journal Citation Reports (2021). Sign in to Continue with Journal Citation Reports. Available online at: https://jcr.clarivate.com/jcr/home (accessed September 19, 2021).
Kleaveland, B., Shi, C. Y., Stefano, J., and Bartel, D. P. (2018). A Network of noncoding regulatory RNAs acts in the mammalian brain. Cell 174, 350–362.e17. doi: 10.1016/j.cell.2018.05.022
Kristensen, L. S., Andersen, M. S., Stagsted, L. V. W., Ebbesen, K. K., Hansen, T. B., and Kjems, J. (2019). The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet. 20, 675–691. doi: 10.1038/s41576-019-0158-7
Lee, R. C., Feinbaum, R. L., and Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854. doi: 10.1016/0092-8674(93)90529-y
Li, Z., Huang, C., Bao, C., Chen, L., Lin, M., Wang, X., et al. (2015). Exon-intron circular RNAs regulate transcription in the nucleus. Nat. Struct. Mol. Biol. 22, 256–264. doi: 10.1038/nsmb.2959
Liu, Q., Zhang, X., Hu, X., Dai, L., Fu, X., Zhang, J., et al. (2016). Circular RNA related to the chondrocyte ECM regulates MMP13 expression by functioning as a MiR-136 ‘Sponge’ in human cartilage degradation. Sci. Rep. 6:22572. doi: 10.1038/srep22572
Liu, S., Sun, Y. P., Gao, X. L., and Sui, Y. (2019). Knowledge domain and emerging trends in Alzheimer’s disease: a scientometric review based on citespace analysis. Neural. Regen. Res. 14, 1643–1650. doi: 10.4103/1673-5374.255995
Lopez-Gonzalez, M. J., Landry, M., and Favereaux, A. (2017). MicroRNA and chronic pain: from mechanisms to therapeutic potential. Pharmacol. Ther. 180, 1–15. doi: 10.1016/j.pharmthera.2017.06.001
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., et al. (2016). The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131, 803–820. doi: 10.1007/s00401-016-1545-1
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., et al. (2013). Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333–338. doi: 10.1038/nature11928
Omuro, A., and DeAngelis, L. M. (2013). Glioblastoma and other malignant gliomas: a clinical review. JAMA 310, 1842–1850. doi: 10.1001/jama.2013.280319
Panni, S., Lovering, R. C., Porras, P., and Orchard, S. (2020). Non-coding RNA regulatory networks. Biochim. Biophys. Acta Gene Regul. Mech. 1863:194417. doi: 10.1016/j.bbagrm.2019.194417
Patop, I. L., and Kadener, S. (2018). circRNAs in Cancer. Curr. Opin. Genet. Dev. 48, 121–127. doi: 10.1016/j.gde.2017.11.007
Piwecka, M., Glazar, P., Hernandez-Miranda, L. R., Memczak, S., Wolf, S. A., Rybak-Wolf, A., et al. (2017). Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science 357:eaam8526. doi: 10.1126/science.aam8526
Sanger, H. L., Klotz, G., Riesner, D., Gross, H. J., and Kleinschmidt, A. K. (1976). Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc. Natl. Acad. Sci. U. S. A. 73, 3852–3856. doi: 10.1073/pnas.73.11.3852
Song, G., Yang, Z., Guo, J., Zheng, Y., Su, X., and Wang, X. (2020). Interactions among lncRNAs/circRNAs, miRNAs, and mRNAs in neuropathic pain. Neurotherapeutics 17, 917–931. doi: 10.1007/s13311-020-00881-y
Tramullas, M., Frances, R., de la Fuente, R., Velategui, S., Carcelen, M., Garcia, R., et al. (2018). MicroRNA-30c-5p modulates neuropathic pain in rodents. Sci. Transl. Med. 10:eaao6299. doi: 10.1126/scitranslmed.aao6299
Wang, Y., Mo, Y., Gong, Z., Yang, X., Yang, M., Zhang, S., et al. (2017). Circular RNAs in human cancer. Mol. Cancer 16:25. doi: 10.1186/s12943-017-0598-7
Westphal, M., and Lamszus, K. (2011). The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat. Rev. Neurosci. 12, 495–508. doi: 10.1038/nrn3060
World Health Organization [WHO] (2021). International Classification of Diseases 11th Revision [Online]. Available online at: https://icd.who.int/en/ (accessed July 9, 2021).
Xu, A. H., and Sun, Y. X. (2020). Research hotspots and effectiveness of repetitive transcranial magnetic stimulation in stroke rehabilitation. Neural Regen. Res. 15, 2089–2097. doi: 10.4103/1673-5374.282269
Xu, H., Zhang, Y., Qi, L., Ding, L., Jiang, H., and Yu, H. (2018). NFIX circular RNA promotes glioma progression by regulating miR-34a-5p via notch signaling pathway. Front. Mol. Neurosci. 11:225. doi: 10.3389/fnmol.2018.00225
Yan, W., Zheng, K., Weng, L., Chen, C., Kiartivich, S., Jiang, X., et al. (2020). Bibliometric evaluation of 2000-2019 publications on functional near-infrared spectroscopy. Neuroimage 220:117121. doi: 10.1016/j.neuroimage.2020.117121
Yang, R., Xing, L., Zheng, X., Sun, Y., Wang, X., and Chen, J. (2019). The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol. Cancer 18:4. doi: 10.1186/s12943-018-0933-7
Zhang, J., Liu, H., Hou, L., Wang, G., Zhang, R., Huang, Y., et al. (2017). Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol. Cancer 16:151. doi: 10.1186/s12943-017-0719-3
Zhang, L., Zhang, Y., Wang, Y., Zhao, Y., Ding, H., and Li, P. (2020). Circular RNAs: functions and clinical significance in cardiovascular disease. Front. Cell Dev. Biol. 8:584051. doi: 10.3389/fcell.2020.584051
Zhang, P., Chao, Z., Zhang, R., Ding, R., Wang, Y., Wu, W., et al. (2019a). Circular RNA regulation of myogenesis. Cells 8:885. doi: 10.3390/cells8080885
Zhang, P. F., Pei, X., Li, K. S., Jin, L. N., Wang, F., Wu, J., et al. (2019b). Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells. Mol. Cancer 18:179. doi: 10.1186/s12943-019-1111-2
Keywords: microRNA, circular RNA, crosstalk, bibliography, cancer
Citation: Chen Y-M, Zheng Y-L, Su X and Wang X-Q (2021) Crosstalk Between MicroRNAs and Circular RNAs in Human Diseases: A Bibliographic Study. Front. Cell Dev. Biol. 9:754880. doi: 10.3389/fcell.2021.754880
Received: 07 August 2021; Accepted: 28 September 2021;
Published: 18 October 2021.
Edited by:
Jing Zhang, Shanghai Jiao Tong University, ChinaReviewed by:
Walter Erwin Kaufmann, Emory University, United StatesYulong Bai, Fudan University, China
Copyright © 2021 Chen, Zheng, Su and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xue-Qiang Wang, wangxueqiang@sus.edu.cn